FDA 510(k) Clearance for Varian’s Vitesse™ Brachytherapy Treatment Planning Software

Varian Medical Systems has gained FDA 510(k) clearance for the latest version of its Vitesse™ real time planning for high dose rate (HDR) brachytherapy which is used to plan and perform HDR, ultrasound-guided brachytherapy treatments for prostate cancer.



Varian Medical Systems Receives FDA 510(k) Clearance for Vitesse™ Brachytherapy Treatment Planning Software (via PR Newswire)

Tool enables clinicians to plan and perform high-dose-rate (HDR) brachytherapy treatments for prostate cancer using real-time ultrasound guidance PALO ALTO, Calif., Jan. 24, 2013 /PRNewswire/ — Varian Medical Systems (NYSE: VAR) has received an FDA 510(k) clearance for the latest version of its Vitesse…


published: January 25, 2013 in: Approval/Clearance, Oncology

Most read

Latest

^